DevelRx will be participating in the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence to be held at the Sheraton Denver Downtown Hotel, Denver, Colorado, USA, 17th-21st June, 2023.
If you are developing novel centrally-acting compounds and would like to learn more about our services come along and meet us at one of our posters.
M164. Experimental Approaches to Screen for Efficacy of Novel Psychedelics. Sharon Smith, Jane Gosden & David Heal. Monday 19th June 2023. 5 pm-6.30 pm. Plaza Exhibit
M169. Valid and Invalid Designs for Conducting Drug Discrimination Experiments in Abuse Potential Evaluations. David Heal, Jane Gosden & Sharon Smith. Monday 19th June 2023. 5 pm-6.30 pm. Plaza Exhibit
T161. Essential Experimental Screening to Evaluate the Safety of Novel Psychedelics. Jane Gosden, Sharon Smith, Christopher Atterwill & David Heal. Tuesday 20th June 2023. 5.15 pm-6.45 pm. Plaza Exhibit
We also have a poster in collaboration with Neumora Therapeutics
S102. NMRA-140, a Novel and Selective Kappa Opioid Receptor Antagonist: Mode of Action Profiling Studies Demonstrate No Opioid Agonist Properties Implicated in Opioid-Related Abuse. Filomene Morrison, Lori Jean Van Orden, Karla Zeitz,David Heal, Sharon Smith & Tanya L. Wallace. Sunday 18th June 2023. 5.15-6.45 pm. Plaza Exhibit.